An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.

The research, published in the journal Proceedings of the National Academy of Sciences, was led by scientists from Flinders University in Australia and South China University of Technology.

It reveals that two enzymes—PDIA1 and PDIA5—play a crucial role in helping prostate cancer cells grow, survive, and resist treatment.